Researchers at Delhi Technological University discover potent anti-cancer compounds in Himalayan tuber Dioscorea deltoidea, ...

Welcome to the world of Liminal Gallery, a fascinating puzzle experience that plays on perspective to solve its puzzles! If you guys remember Superliminal, a game we played on the channel ...

Sacituzumab govitecan combined with pembrolizumab improved progression-free survival in PD-L1–positive metastatic triple-negative breast cancer compared with chemotherapy. Vepdegestrant, a ...

Google Drive offers 15GB of storage for free, although this storage is shared with Gmail and Google Photos. Paid plans through Google One start at 100GB for $1.99/month and go up to 30TB for $149. ...

By John Vandermosten, CFA NASDAQ:LTRN A May 5 th press release indicated that the FDA cleared Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-184 trial in triple negative breast cancer (TNBC). Lantern ...

Triple negative breast cancer is aggressive and hard to treat. It also disproportionately affects Black women. A University of Kansas medical researcher is working to find out why and expand treatment ...

Pharma Gilead's Trodelvy-Keytruda proposal hits goal in first-line triple-negative breast cancer By Angus Liu Apr 21, 2025 11:29am Gilead Sciences Trodelvy antibody-drug conjugates Keytruda ...

TNBC Thrivers also has a Facebook Group with almost 300 members who share their struggles and wins. No matter where people find TNBC Thrivers, Thomas wants them to discover success stories ...

More information: Liqun Yu et al, Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer, Immunity (2025).

“For triple-negative breast cancer (TNBC), a combination of pembrolizumab (an anti-PD-1 antibody) and chemotherapies has been approved to treat advanced tumors in the neoadjuvant setting.” ...

Diagnosing triple negative breast cancer involves several steps beyond identifying the presence of cancer cells. After detecting an abnormality through imaging or physical examination, doctors ...

Ciara Foskin’s diagnosis came out of the blue. She is part of a small cohort of women under 50 who develop triple-negative breast cancer in Ireland Ciara Foskin, 47, was shocked to be told she ...